Australia ahead of NZ in cancer survival rates

It’s calling for major changes to cancer planning and co-ordination in New Zealand, based on the findings of a new international study published in the Lancet medical journal last month.

New cancer treatments could make chemotherapy a thing of the past

Chemotherapy could become a thing of the past for up to two-in-three cancer patients, as the federal government considers subsidising new immunotherapy treatments.

Dr. Sullivan on Targeted Therapy for BRAF-Mutant Melanoma

Ryan J. Sullivan, MD, instructor of Medicine, Harvard Medical School, assistant in medicine, MGH Cancer Center, Massachusetts General Hospital, discusses novel molecular targets in patients with melanoma.

Skin cancer: Hairdressers and beauticians being trained to spot killer disease

HAIRDRESSERS and beauticians are being trained to spot skin cancer in a bid to reduce the number of young people dying from the disease.

Cancer in the News

Feature Articles

Visible Melanoma Lesions Affect Patients’ Physical, Emotional Quality of Life

A recent study highlighted the additional psychological effects that patients with locally advanced cutaneous melanoma go through, particularly because their lesions are a visible part of their everyday life.

Read the full story

Posted in Melanoma In The News, Information

Updates in Targeted Combination Therapies for Melanoma

Approximately 40% of melanoma cases harbor BRAF mutations that are able to be targeted, and with the advent of the combination of dabrafenib (Tafinlar) plus trametinib (Mekinist) demonstrating impressive outcomes in patients with BRAF mutations, physicians are no longer using BRAF inhibitors alone, but rather in combination with MEK inhibitors due to the improved efficacy.

Read the full story

Posted in Melanoma In The News, Information

Versatile Sensor Against Tumor Initiating Cells

Most cancer deaths are caused by recurrent or metastatic tumors.

Read the full story

Posted in Melanoma In The News, Information

Larger Trials Needed to Confirm Benefit of Targeted Therapies, Immunotherapy for Brain Metastases

Brain metastases are a common complication of a variety of cancer types and a major cause of morbidity and mortality.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories